Silenor and Speech disorder - a phase IV clinical study of FDA data

Summary:

Speech disorder is reported as a side effect among people who take Silenor (doxepin hydrochloride), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Saphris, and have Bipolar i disorder.

The phase IV clinical study analyzes which people have Speech disorder when taking Silenor. It is created by eHealthMe based on reports of 583 people who have side effects when taking Silenor from the FDA, and is updated regularly.

What is Silenor?

Silenor has active ingredients of doxepin hydrochloride. It is often used in insomnia. eHealthMe is studying from 635 Silenor users. Check the latest studies of Silenor.

What is Speech disorder?

Speech disorder is found to be associated with 1,806 drugs and 2,281 conditions by eHealthMe. Check the latest studies of Speech disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

583 people reported to have side effects when taking Silenor.
Among them, 16 people (2.74%) have Speech disorder.

Among these 16 people:

How long have people been on Silenor when they have Speech disorder? *

What is the gender of people who have Speech disorder when taking Silenor? *

female: 20 %
male: 80 %

What is the age of people who have Speech disorder when taking Silenor? *

What are other drugs people take besides Silenor? *

What are other side effects people have besides Speech disorder? *

Drowsiness: 13 people, 81.25%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 75.00%
Dyspnea (difficult or laboured breathing): 12 people, 75.00%
Pain: 12 people, 75.00%
Hallucinations (sensations that appear real but are created by your mind): 12 people, 75.00%
Fall: 11 people, 68.75%
Hyperhidrosis (abnormally increased sweating): 11 people, 68.75%
Pulse Absent: 11 people, 68.75%
Rib Fracture: 11 people, 68.75%
Listless (lack of interest, energy, or spirit): 11 people, 68.75%

What are the existing conditions these people have? *

Weight Loss: 1 person, 6.25%
Post-Traumatic Stress Disorder: 1 person, 6.25%
Pain In Extremity: 1 person, 6.25%
Pain: 1 person, 6.25%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 6.25%
Dizziness: 1 person, 6.25%
Depression: 1 person, 6.25%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Silenor and have Speech disorder?

- Check whether Speech disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Silenor:

Silenor (635 reports)

Speech disorder treatments and more:

Speech disorder (62,574 reports)

Browse all side effects of Silenor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech disorder:

Speech disorder (1,806 drugs)

Browse all the conditions that are associated with Speech disorder:

Speech disorder (2,281 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxepin hydrochloride (the active ingredients of Silenor) and Silenor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.